MET and triple-negative breast carcinoma: We selected the MDA-MB-231 cell line, a commonly used model of triple-negative breast cancer [25], and analyzed single cell transcriptomes of parental cells before selection (D0) and “revertant” cells selected in met–hcys+ medium for 21 days (D21).